A clinical assay for the measurement of milrinone in plasma by HPLC mass spectrometry.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Biomedical chromotography

• Publication date

  2012-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/bmc.1675PMID 21905056
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Is monitoring milrinone therapy useful in advanced heart failure?

  2011cited by this paper
• High performance liquid chromatography using UV detection for the quantification of milrinone in plasma: improved sensitivity for inhalation.

  2009cited by this paper
• Comparison of inhaled and intravenous milrinone in patients with pulmonary hypertension undergoing mitral valve surgery

  2009cited by this paper
• The use of continuous milrinone therapy as bridge to transplant is safe in patients with short waiting times.

  2008cited by this paper
• A sensitive and specific high performance liquid chromatographic assay for milrinone in rat and human plasma using a commercially available internal standard and low sample volume.

  2005cited by this paper
• Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry.

  2005cited by this paper
• Pharmacokinetics and effects on blood pressure of a single oral dose of milrinone in healthy subjects and in patients with renal impairment

  2004cited by this paper
• Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS.

  2003cited by this paper
• Pharmacokinetics of milrinone in patients with congestive heart failure during continuous venovenous hemofiltration

  2000cited by this paper
• Milrinone for long-term pharmacologic support of the status 1 heart transplant candidates.

  2000cited by this paper
• Pharmacodynamics and pharmacokinetics of milrinone administration to increase oxygen delivery in critically ill patients.

  1996cited by this paper
• Pharmacodynamics and Pharmacokinetics of Milrinone Administration to Increase Oxygen Delivery in Critically III Patients

  1996cited by this paper
• Dose Regimen Adjustment for Milrinone in Congestive Heart Failure Patients with Moderate and Severe Renal Failure

  1995cited by this paper
• A Pharmacokinetic and Pharmacodynamic Evaluation of Milrinone in Adults Undergoing Cardiac Surgery

  1995cited by this paper
• Pharmacokinetics of Intravenous Milrinone in Patients Undergoing Cardiac Surgery

  1994cited by this paper
• Pharmacokinetics of intravenous milrinone in patients undergoing cardiac surgery.

  1994cited by this paper
• Method validation in the bioanalytical laboratory.

  1990cited by this paper
• Analysis of milrinone in plasma using solid-phase extraction and high-performance liquid chromatography.

  1986cited by this paper
• Acute dose range study of milrinone in congestive heart failure.

  1985cited by this paper
• High-performance liquid chromatographic analysis of milrinone in plasma and urine. Intravenous pharmacokinetics in the dog.

  1983cited by this paper

• Review of Chromatographic Methods Coupled with Modern Detection Techniques Applied in the Therapeutic Drugs Monitoring (TDM)

  2020cites this paper
• Developmental Pharmacokinetics and Age-Appropriate Dosing Design of Milrinone in Neonates and Infants with Acute Kidney Injury Following Cardiac Surgery

  2019cites this paper
• A sensitive method for the simultaneous UHPLC-MS/MS analysis of milrinone and dobutamine in blood plasma using NH4F as the eluent additive and ascorbic acid as a stabilizer.

  2019cites this paper
• Milrinone therapeutic drug monitoring in a pediatric population: Development and validation of a quantitative liquid chromatography-tandem mass spectrometry method.

  2017cites this paper
• Milrinone in Advanced Heart Failure

  2014cites this paper
• A Specific and Sensitive HPLC–MS/MS Micromethod for Milrinone Plasma Levels Determination After Inhalation in Cardiac Patients

  2014cites this paper
• Clinical applications of fast liquid chromatography: a review on the analysis of cardiovascular drugs and their metabolites.

  2013cites this paper